Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).

Clinical trial NCT04260711 · UNKNOWN

Trial details

NCT number: NCT04260711
Sponsor: Amsterdam UMC, location VUmc
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Secondary Progressive

Start date: 2020-07-01
Primary completion: 2023-08-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.